Patents by Inventor Steve L. Nierlich

Steve L. Nierlich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7415298
    Abstract: A pulse oximeter sensor with a light source optimized for low oxygen saturation ranges and for maximizing the immunity to perturbation induced artifact. Preferably, a red and an infrared light source are used, with the red light source having a mean wavelength between 700-790 nm. The infrared light source can have a mean wavelength as in prior art devices used on patients with high saturation. The sensor of the present invention is further optimized by arranging the spacing between the light emitter and light detectors to minimize the sensitivity to perturbation induced artifact. The present invention optimizes the chosen wavelengths to achieve a closer matching of the absorption and scattering coefficient products for the red and IR light sources. This optimization gives robust readings in the presence of perturbation artifacts including force variations, tissue variations and variations in the oxygen saturation itself.
    Type: Grant
    Filed: February 23, 2007
    Date of Patent: August 19, 2008
    Assignee: Nellcor Puritan Bennett Inc.
    Inventors: James R. Casciani, Paul D. Mannheimer, Steve L. Nierlich, Stephen J. Ruskewicz
  • Patent number: 7349726
    Abstract: Embodiments of the present invention are directed to a system and method for measuring blood oxygen saturation. Specifically, embodiments of the present invention include emitting light having a wavelength spectrum that is optimized for an oxygen saturation reading less than 80 percent, detecting the light, and transmitting signals based on the detected light, the signals being useful in determining blood oxygen saturation with a pulse oximeter.
    Type: Grant
    Filed: April 19, 2006
    Date of Patent: March 25, 2008
    Assignee: Nellcor Puritan Bennett LLC
    Inventors: James R. Casciani, Paul D. Mannheimer, Steve L. Nierlich, Stephen J. Ruskewicz
  • Publication number: 20040204639
    Abstract: A pulse oximeter sensor with a light source optimized for low oxygen saturation ranges and for maximizing the immunity to perturbation induced artifact. Preferably, a red and an infrared light source are used, with the red light source having a mean wavelength between 700-790 nm. The infrared light source can have a mean wavelength as in prior art devices used on patients with high saturation. The sensor of the present invention is further optimized by arranging the spacing between the light emitter and light detectors to minimize the sensitivity to perturbation induced artifact. The present invention optimizes the chosen wavelengths to achieve a closer matching of the absorption and scattering coefficient products for the red and IR light sources. This optimization gives robust readings in the presence of perturbation artifacts including force variations, tissue variations and variations in the oxygen saturation itself.
    Type: Application
    Filed: October 30, 2003
    Publication date: October 14, 2004
    Applicant: Nellcor Puritan Bennett Incorporated
    Inventors: James R. Casciani, Paul D. Mannheimer, Steve L. Nierlich, Stephen J. Ruskewicz
  • Patent number: 6662033
    Abstract: A pulse oximeter sensor with a light source optimized for low oxygen saturation ranges and for maximizing the immunity to perturbation induced artifact. Preferably, a red and an infrared light source are used, with the red light source having a mean wavelength between 700-790 nm. The infrared light source can have a mean wavelength as in prior art devices used on patients with high saturation. The sensor of the present invention is further optimized by arranging the spacing between the light emitter and light detectors to minimize the sensitivity to perturbation induced artifact. The present invention optimizes the chosen wavelengths to achieve a closer matching of the absorption and scattering coefficient products for the red and IR light sources. This optimization gives robust readings in the presence of perturbation artifacts including force variations, tissue variations and variations in the oxygen saturation itself.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: December 9, 2003
    Assignee: Nellcor Incorporated
    Inventors: James R. Casciani, Paul D. Mannheimer, Steve L. Nierlich, Stephen J. Ruskewicz
  • Publication number: 20020082489
    Abstract: A pulse oximeter sensor with a light source optimized for low oxygen saturation ranges and for maximizing the immunity to perturbation induced artifact. Preferably, a red and an infrared light source are used, with the red light source having a mean wavelength between 700-790 nm. The infrared light source can have a mean wavelength as in prior art devices used on patients with high saturation. The sensor of the present invention is further optimized by arranging the spacing between the light emitter and light detectors to minimize the sensitivity to perturbation induced artifact. The present invention optimizes the chosen wavelengths to achieve a closer matching of the absorption and scattering coefficient products for the red and IR light sources. This optimization gives robust readings in the presence of perturbation artifacts including force variations, tissue variations and variations in the oxygen saturation itself.
    Type: Application
    Filed: June 14, 2001
    Publication date: June 27, 2002
    Inventors: James R. Casciani, Paul D. Mannheimer, Steve L. Nierlich, Stephen J. Ruskewicz
  • Patent number: 6272363
    Abstract: A pulse oximeter sensor with a light source optimized for low oxygen saturation ranges and for maximizing the immunity to perturbation induced artifact. Preferably, a red and an infrared light source are used, with the red light source having a mean wavelength between 700-790 nm. The infrared light source can have a mean wavelength as in prior art devices used on patients with high saturation. The sensor of the present invention is further optimized by arranging the spacing between the light emitter and light detectors to minimize the sensitivity to perturbation induced artifact. The present invention optimizes the chosen wavelengths to achieve a closer matching of the absorption and scattering coefficient products for the red and IR light sources. This optimization gives robust readings in the presence of perturbation artifacts including force variations, tissue variations and variations in the oxygen saturation itself.
    Type: Grant
    Filed: January 6, 1998
    Date of Patent: August 7, 2001
    Assignee: Nellcor Incorporated
    Inventors: James R. Casciani, Paul D. Mannheimer, Steve L. Nierlich, Stephen J. Ruskewicz
  • Patent number: 5839439
    Abstract: An oximeter sensor formed with a housing made of a relatively rigid material into which the oximeter electrical components can be mounted is provided. An overmolded material, of lesser rigidity, is injection-molded over the housing to complete the sensor. In one embodiment the housing is made of plastic, such as polypropylene, and the overmolded material is an injection-molded thermal plastic elastomer, such as Santoprene.TM. (polypropylene with 1 micron size particles of rubber). The housing preferably contains thin portions connecting thicker portions which support the electrical and optical components. These thin portions provide natural bending portions in the final oximeter sensor. By having the thin portions near or at the central, neutral axis of the sensor, flexibility is optimized in the longitudinal direction, while the housing provides stiffness laterally.
    Type: Grant
    Filed: November 13, 1995
    Date of Patent: November 24, 1998
    Assignee: Nellcor Puritan Bennett Incorporated
    Inventors: Steve L. Nierlich, Phillip S. Palmer, James R. Casciani, Mitch Levinson, Stephen J. Ruskewicz
  • Patent number: 5782237
    Abstract: A pulse oximeter sensor with a light source optimized for low oxygen saturation ranges and for maximizing the immunity to perturbation induced artifact. Preferably, a red and an infrared light source are used, with the red light source having a mean wavelength between 700-790 nm. The infrared light source can have a mean wavelength as in prior art devices used on patients with high saturation. The sensor of the present invention is further optimized by arranging the spacing between the light emitter and light detectors to minimize the sensitivity to perturbation induced artifact. The present invention optimizes the chosen wavelengths to achieve a closer matching of the absorption and scattering coefficient products for the red and IR light sources. This optimization gives robust readings in the presence of perturbation artifacts including force variations, tissue variations and variations in the oxygen saturation itself.
    Type: Grant
    Filed: March 30, 1995
    Date of Patent: July 21, 1998
    Assignee: Nellcor Puritan Bennett Incorporated
    Inventors: James R. Casciani, Paul D. Mannheimer, Steve L. Nierlich, Stephen J. Ruskewicz
  • Patent number: 5660567
    Abstract: A connector for a medical sensor is provided. The connector includes a number of contacts, and includes an electronic device for encoding a characteristic of the medical sensor. The electronic device is insertable into the connector. This simplifies the design of a sensor, which no longer needs to include a calibration element. In addition, the sensor can be made more cheaply, which is especially important for disposable sensors.
    Type: Grant
    Filed: November 14, 1995
    Date of Patent: August 26, 1997
    Assignee: Nellcor Puritan Bennett Incorporated
    Inventors: Steve L. Nierlich, Phillip S. Palmer, Adnan I. Merchant
  • Patent number: 5421329
    Abstract: A pulse oximeter sensor with a light source optimized for low oxygen saturation ranges and for maximizing the immunity to perturbation induced artifact. Preferably, a red and an infrared light source are used, with the red light source having a mean wavelength between 700-790 nm. The infrared light source can have a mean wavelength as in prior art devices used on adults. The sensor of the present invention is further optimized by arranging the spacing between the light emitter and light detectors to minimize the sensitivity to perturbation induced artifact. The present invention optimizes the chosen wavelengths to achieve a closer matching of the absorption and scattering coefficient products for the red and IR light sources. This optimization gives robust readings in the presence of perturbation artifacts including force variations, tissue variations and variations in the oxygen saturation itself.
    Type: Grant
    Filed: April 1, 1994
    Date of Patent: June 6, 1995
    Assignee: Nellcor, Inc.
    Inventors: James R. Casciani, Paul D. Mannheimer, Steve L. Nierlich, Stephen J. Ruskewicz
  • Patent number: D384643
    Type: Grant
    Filed: November 14, 1995
    Date of Patent: October 7, 1997
    Assignee: Nellcor Puritan Bennett Incorporated
    Inventors: Steve L. Nierlich, Phillip S. Palmer